Ben Jones of PCI Pharma Services explores the attractiveness of the US drug market for selling pharmaceutical therapies. With a population of more than 330 million people, it is valued at $358 billion annually and represents approximately 44% of the total global pharmaceutical market. Pharmaceutical companies operating in the United States are now expected to have taken
initial steps in securing their supply chain, complying with the Drug Safety and Supply Chain Act (DSCSA) effective November of 2017.
Current Edition
Current Edition
CDMO Subsection
Insights into the latest developments in CDMO services and manufacturing.
Continue readingInjectables Subsection
Expert perspectives on the evolving needs of injectable therapies and packaging.
Continue readingNasal & Pulmonary Subsection
Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability
Continue reading
Serialisation and Data Connectivity – the New Wrinkle in your Supply Chain
